Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01495403 · ClinicalTrials.gov registry record · Early Phase 1
Treatment of Muscle Cramps in Patients With Liver Cirrhosis
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT01495403: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT01495403 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01495403, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
This is a pilot study to see if hydroxychloroquine (HCQ) if safe and effective to use with patients having cramps due to their cirrhotic liver disease.
Interventions
- DRUG Hydroxychloroquine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2011-12 |
| Est. Completion | 2015-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01495403
The ClinicalTrials.gov registry entry for NCT01495403 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hydroxychloroquine is the first listed.
NCT01495403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01495403 about?
NCT01495403 is a clinical study titled "Treatment of Muscle Cramps in Patients With Liver Cirrhosis". This is a pilot study to see if hydroxychloroquine (HCQ) if safe and effective to use with patients having cramps due to their cirrhotic liver disease.
What is the current status of trial NCT01495403?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2011-12. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01495403?
The interventions under investigation include: Hydroxychloroquine (DRUG).
Who is sponsoring clinical trial NCT01495403?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.